Sugi Predict

Sugi Predict / Compounds / SCHEMBL25739

SCHEMBL25739

SCHEMBL25739

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ NMUR2 Q9GZQ4 5/20 0.64
▸ NMUR1 Q9HB89 5/20 0.64
▸ F2 P00734 4/20 0.63
▸ NPY1R P25929 4/20 0.59
▸ NPY2R P49146 4/20 0.59
▸ NPY4R P50391 4/20 0.59
▸ NPY5R Q15761 4/20 0.59
▸ OPRD1 P41143 1/20 0.59
▸ NTSR1 P30989 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23278082 1.00 NMUR2 (0.64) NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL29389211 1.00 NMUR2 (0.64) NMUR2NMUR1F2NPY1RNPY2R
Acetic Acid SCHEMBL2037978 0.99 NMUR2 (0.63) NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL28366588 0.99 NMUR2 (0.65) NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL30753221 0.99 NMUR2 (0.61) NMUR2NMUR1F2NPY1RNPY2R
SCHEMBL23630197 0.98 NMUR2 (0.62) NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL4139781 0.98 NMUR2 (0.61) NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL2034151 0.98 NMUR2 (0.61) NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL29454826 0.98 NMUR2 (0.61) NMUR2NMUR1F2NPY1RNPY2R
Trifluoroacetic Acid SCHEMBL16029740 0.97 NMUR2 (0.61) NMUR2NMUR1F2NPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 24013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103722-A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF COAGULATION FACTOR XI (FXI) SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. (CN) 2026-05-21 — — WO claimed
US-12623010-B2 Blood oxygenator with an organic membrane UNIWERSYTET SLASKI (PL) 2026-05-12 — — US claimed
CN-122006502-A Photo-thermal sterilization anticoagulation hemodialysis membrane and preparation method thereof 四川大学 2026-05-12 — — CN claimed
US-20260124148-A1 POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY BHAMIS RES LABORATORY PVT LTD (IN) 2026-05-07 — — US claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 — — EP claimed
US-20260115299-A1 CALSEQUESTRIN-BASED METAL ION REACTIVE PARTICLE AND USES THEREOF TOOLBIO CO LTD (KR) 2026-04-30 — — US claimed
US-12605371-B2 Combination therapy for cancer THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2026-04-21 — — US claimed
US-20260097063-A1 ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES REGENERON PHARMA (US) 2026-04-09 — — US claimed
US-12589187-B2 Valve material with combined anti-clotting and anti-calcification properties and preparation method JILIN VENUS HAOYUE MEDICAL LIMITED (CN) 2026-03-31 — — US claimed
EP-4705465-A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF COAGULATION FACTOR XI (FXI) Shanghai Argo Biopharmaceutical Co., Ltd. (CN) 2026-03-11 — — EP claimed
US-5399352-A Device for local drug delivery and methods for using the same EMORY UNIVERSITY (US) 1995-03-21 — — US claimed
WO-1995006487-A2 INTRAVASCULAR MEDICAL DEVICE MED INSTITUTE, INC. (US) 1995-03-09 — — WO claimed
WO-1994023668-A1 A DEVICE FOR LOCAL DRUG DELIVERY AND METHODS FOR USING THE SAME EMORY UNIVERSITY (US) 1994-10-27 — — WO claimed
US-5196404-A Hirudin mimic, polypeptide, hirulog; bivalirudin FDA Orange book listed patent BIOGEN, INC. (US) 1993-03-23 — — US claimed
EP-0489070-A1 NOVEL INHIBITORS OF THROMBIN. BIOGEN INC (US) 1992-06-10 — — EP claimed
EP-0482069-A1 COMBINATIONS AND METHODS FOR TREATING OR PREVENTING THROMBOTIC DISEASES BIOGEN, INC. (US) 1992-04-29 — — EP claimed
WO-1991002750-A1 NOVEL INHIBITORS OF THROMBIN BIOGEN, INC. (US) 1991-03-07 — — WO claimed
WO-1991001142-A1 COMBINATIONS AND METHODS FOR TREATING OR PREVENTING THROMBOTIC DISEASES BIOGEN, INC. (US) 1991-02-07 — — WO claimed
WO-1990003391-A1 HIRUDIN PEPTIDES BIOGEN, INC. (US) 1990-04-05 — — WO claimed
EP-0333356-A2 Hirudin peptides BIOGEN, INC. (US) 1989-09-20 — — EP claimed
Send feedback